Premium
Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation
Author(s) -
Cranwell William C,
Sinclair Rodney
Publication year - 2017
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12499
Subject(s) - medicine , minoxidil , scarring alopecia , hydroxychloroquine , dermatology , hair loss , triamcinolone acetonide , folliculitis , transplantation , surgery , alopecia universalis , hair transplantation , scalp , infectious disease (medical specialty) , disease , covid-19
A 46‐year‐old premenopausal woman presented with familial frontal fibrosis alopecia affecting the temples bilaterally. The diagnosis was confirmed histologically. Her past history included rheumatoid arthritis treated with hydroxychloroquine 400 mg daily and methotrexate 20 mg weekly. Serial intralesional injections of triamcinolone did not limit the progression of hair loss. Treatment with dutasteride 0.1 mg daily and minoxidil 1 mg daily stabilised hair loss and artificial fibre hair transplantation initially led to a satisfactory cosmetic outcome. Unfortunately, the patient developed implant folliculitis uncontrolled by antibiotics, necessitating the removal of the fibres 12 months post‐transplantation.